Thompson Siegel & Walmsley’s Bausch Health BHC Stock Holding History

Thompson Siegel & Walmsley’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40	Closed	-$1K	–	639
2021 Q4	$1K	Sell	40 -660,370	-100%	-$17.7M	﹤0.01%	618
2021 Q3	$18.4M	Sell	660,410 -863,744	-57%	-$24.5M	0.27%	98
2021 Q2	$44.7M	Buy	1,524,154 +148,070	+11%	+$4.49M	0.61%	59
2021 Q1	$43.7M	Buy	+1,376,084	New	+$40.4M	0.62%	59
2015 Q2	–	Sell	-300	Closed	-$60K	–	694
2015 Q1	$60K	Buy	+300	New	+$53.2K	﹤0.01%	471

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

GCC

Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

Thompson Siegel & Walmsley's BHC Position: Q1 2022 in Review

Thompson Siegel & Walmsley sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 40 shares — an estimated $1K sold.

Thompson Siegel & Walmsley first reported a position in BHC in Q1 2015 and held it in 5 quarters. The position peaked at $44.7M in Q2 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

Thompson Siegel & Walmsley reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
Thompson Siegel & Walmsley sold 40 Bausch Health shares in Q1 2022, an estimated $1K.
Thompson Siegel & Walmsley first reported a position in Bausch Health in Q1 2015 and held it in 5 quarters.
Thompson Siegel & Walmsley's Bausch Health position peaked at $44.7M in Q2 2021.
370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2022, filed 26 Apr 2022.